NEOG

Rating buyAI Memo

Neogen

As of 2026-01-28/Confidence medium

Open ticker Back to Memos

Data freshness

AI Memo

As of 2026-01-28 • Model: RankAlpha Sentiment AI

Decision Panel

Action, confidence, horizon, and decision blockers at a glance.

Action

buy

Confidence

medium

Horizon

—

Key catalyst

Analyst target revisions / consensus updates • 2026-03-31

Expected move: +7%

Biggest risk

Slower end‑market demand or execution delays compress revenue and margins, pushing share price toward the low end of analyst targets.

Invalidation

Break below $7 or thesis failure.

What would change my mind?

Recovery in volumes and favorable analyst revisions lift valuation toward the upper analyst band; operational execution improves margins.

Research note

Recommendation

buy

Confidence

medium

As of

2026-01-28

Base target

$11

p=60%

Bull target

$14

p=20%

Bear target

p=20%

Key bullets

Fast scan of bull, bear, and watch items

BullKey bullets

Next quarterly earnings release
Multi‑quarter top‑line/market-share recovery
Recovery in volumes and favorable analyst revisions lift valuation toward the upper analyst band; operational execution improves margins.

BearKey bullets

Analyst downgrades or consensus cuts
Execution or integration setbacks
Weaker-than-expected end-market volumes

WatchKey bullets

Analyst target revisions / consensus updates

Summary

High-level snapshot

Recommendation

buy

Model confidence

medium

Timeframe

Asset

Equity

Trigger

Base case: $11 (p=60%)

Bull/Bear spread: +37% / -35%

Vs latest close: Bull +37% · Base +7% · Bear -35%

Scenario probabilities

Bull Target: $14 (p=20%)Base Target: $11 (p=60%)Bear Target: $7 (p=20%)

Commentary

Market commentary shows mixed-to-muted sentiment with several services and coverage notes clustering around mid‑teens upside vs. current price [#SERP-2]. Recent syndicated target updates raise the upper bound but leave dispersion large [#SERP-4]. Overall tone is cautious‑positive as analysts balance recovery potential against execution risk [#SERP-5].

As of 2026-01-28 • Updated bi-weekly / post-earningsSource: Internal modelMethodology

Analyst Summary

Thesis highlights from the latest analysis

Bull Case

Recovery in volumes and favorable analyst revisions lift valuation toward the upper analyst band; operational execution improves margins.

Bear Case

Slower end‑market demand or execution delays compress revenue and margins, pushing share price toward the low end of analyst targets.

Drivers

Scannable catalysts and supporting factors

Next quarterly earnings release
Multi‑quarter top‑line/market-share recovery

Human Analyst Targets

External snippets for comparison only; verify at source.

Unverified externalLast fetched 2026-01-28Source quality: external scrape

External snippets are unverified; treat as directional signals only. Always confirm with the original provider.

Inline RA est

Provider

serper

Median (USD)

$10.67

Range (USD)

$6.50 - $13.65

Count

Query: Neogen Corp Common (NEOG) analyst consensus price target high low average

Neogen Corporation (NEOG) Stock Price, News, Quote & History
Search result #1
NEOGEN CORP has an Investment Rating of HOLD; a target price of $7.000000; an Industry Subrating of High; a Management Subrating of Low; a Safety Subrating of ...
Extracted: $7.00Open source
Neogen Corp (NEOG) Stock Forecast, Price Targets and Analysts ...
Search result #2
The average price target is $10.67 with a high forecast of $12.00 and a low forecast of $10.00. The average price target represents a 8.88% change from the last ...
Extracted: $10.67, $12.00, $10.00Open source
Neogen Consensus Estimates (NEOG) - Investing.com NG
Search result #3
The highest analyst price target is USD10, and the lowest is USD6.5. What Is NEOG's Potential Upside or Downside, Based on the Analysts' Average Price Target?
Extracted: $10.00, $6.50Open source
Neogen (NEOG) Price Target Increased by 44.26% to 11.22 - Fintel
Search result #4
The latest targets range from a low of $9.09 to a high of $13.65 / share. The average price target represents an increase of 21.96% from the ...
Extracted: $9.09, $13.65Open sourceJan 9, 2026
NEOG | Neogen Corp. Analyst Estimates - MarketWatch
Search result #5
Stock Price Targets. High, $13.00. Median, $11.00. Low, $9.00. Average, $11.00. Current Price, $9.93. Yearly Numbers. Estimates. NEOG will report 2026 earnings ...
Extracted: $13.00, $11.00, $9.00, $9.93Open source
What is the current Price Target and Forecast for Neogen (NEOG)
Search result #6
made by 5 brokerage firms. The average price target for Neogen Corporation (NEOG) is $11.67. The current on short-term price targets is based on 3 reports.
Extracted: $11.67Open source

Scenarios

Bull Target (Scenario probability)

$14 / p=20% prob

Base Target (Scenario probability)

$11 / p=60% prob

Bear Target (Scenario probability)

$7 / p=20% prob

Price $10 as of 2026-07-21

Nearest Scenario: Base (∆ 7%)

Targets vs latest close: Bull +37% · Base +7% · Bear -35%

Sentiment & Exposure

Sentiment unavailable: insufficient coverage

Events

Other notable items detected

EVENT2026-03-31
Analyst target revisions / consensus updates
Ongoing analyst re-ratings and target dispersion have driven recent target range; follow-up revisions likely as coverage updates arrive (observed recent updates) [#SERP-4], assumption uses window end as date.
Prob 60.00% • Move 15.00% • Priced-in 30.00%

Short-term Catalysts

Next few weeks

Next quarterly earnings release
2026-04-28
Quarterly results and management commentary may reprice shares vs. small analyst upside; timing estimated (no public calendar date) so using short-window estimate and analyst note context [#SERP-5].
Prob 75% • Move 8% • Priced-in 40%

Long-term Catalysts

Months to a year

Multi‑quarter top‑line/market-share recovery
2027-01-28
If volumes and new product adoption recover vs. peers, multi‑quarter revenue improvement could support higher multiple; long horizon estimate used given uncertain timing [#SERP-2].
Prob 40% • Move 35% • Priced-in 20%

Risks

Analyst downgrades or consensus cuts
Execution or integration setbacks
Weaker-than-expected end-market volumes

Peers

Symbol	Summary
IDXX	Animal diagnostics leader with greater scale; useful comparator for animal-health exposure.
BIO	Diagnostics and life‑science tools peer with overlapping testing markets and lab services exposure.
TMO	Broad scientific instruments and reagents firm; larger-scale comparator for testing/analytics demand trends.

Sources

Internal and external references used in this analysis

Model source: RankAlpha Sentiment AI
Human targets: serper
Targets query: Neogen Corp Common (NEOG) analyst consensus price target high low average
Analysis date: 2026-01-28

AI Stock Memo: NEOG - Neogen - RankAlpha